Health Care

Denmark's Novo Nordisk, the world's biggest maker of insulin, went public with a 2.6 billion euro ($3.1 billion) bid for Belgian biotech group Ablynx on Monday as it seeks to bolster its treatments for rare blood disorders.

U.S. biotech pharmaceutical firm Celgene Corp said on Sunday that it had agreed to acquire Impact Biomedicines for as much as $7 billion, subject to certain milestones associated with regulatory hurdles and sales performance.

Pfizer is abandoning research to find new drugs aimed at treating Alzheimer's and Parkinson's disease, the U.S. pharmaceutical company announced on Saturday.

Japanese air bag maker Takata is recalling another 3.3 million faulty air bag inflators as it continues to expand the largest automotive recall in U.S. history.

The state's Agency for Health Care Administration said in a Friday evening news release that one of its employees "was the victim of a malicious phishing email" on Nov. 15.

Stocks that moved substantially or traded heavily Friday: Constellation Brands Inc., down $5.91 to $219.88

Under a new agreement, Highmark health insurance will maintain in-network access to University of Pittsburgh Medical Center hospitals in western Pennsylvania.

The inception of a new drug that offers a cure for a retinol eye disorder is a game changer according to Fox News medical correspondent Dr. Marc Siegel.

A first-of-its kind genetic treatment for blindness is among the most expensive genetic therapies in the world.

Cityblock Health said on Thursday it received $20.8 million in a first round of funding from Maverick Ventures, Thrive Capital and Sidewalk Labs, the subsidiary of Alphabet Inc that founded Cityblock.

Ford says it will repair any coolant leaks that might be found in more than 200,000 recalled vehicles that are at risk of catching fire.

Dr. Marc Siegel discusses concerns over the effectiveness of the current flu vaccine.

Small business owners have entered 2018 with many questions about how big their tax bills will be, but they're also optimistic about profiting from a strong economy.

Sangamo Therapeutics Inc and Pfizer Inc said on Wednesday they would work together to develop a gene therapy to treat ALS, a disease that affects nerve cells in the brain and the spinal cord.

A U.S. court on Tuesday asked Valeant Pharmaceuticals International and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.

U.S. stocks are starting the new year higher thanks in part to gains in technology companies and retailers, some of the market's biggest gainers from 2017.